Prospective Database of Factors Associated With Faecal vs. Double Incontinence in Patients
This study aims to verify the results from our previous retrospective cohort analysis by establishing a database of well-characterised patients prospectively. The different prevalence of neurological disorders, abdominal, urological and obstetrical surgery, diarrhoea and other potential associated factors as well as th
| Condition(s) | Double Incontinence, Faecal Incontinence, Urinary Incontinence |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | This study aims to verify the results from our previous retrospective cohort analysis by establishing a database of well-characterised patients prospectively. The different prevalence of neurological disorders, abdominal, urological and obstetrical surgery, diarrhoea and other potential associated factors as well as the importance of abnormalities identified by 3D high resolution anorectal manometry (HARM) will be compared between subjects with feacal incontinence (FI), double incontinence (DI) and controls. Presence and severity of both FI and urinary incontinence (UI) will be evaluated by disease specific questionnaires. Measuring both disease severity and Quality of Life (QoL) is needed to determine the true impact of incontinence. Finally, the impact on quality of life will be compared |
| Who can participate | Inclusion Criteria: * Age \> 18 years; * Self-reported faecal incontinence. Exclusion Criteria: * Impossibility to perform the anorectal manometry because of pain, stenosis or organic disease; * Active (peri)rectal inflammation, including abscess; * Pregnancy; * Inability to cooperate during the anorectal manometry * Impossibility to perform HARM due to pain, stenosis or organic disease; * Inability to complete the questionnaires |
| Ages | 18 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Universitair Ziekenhuis Brussel |
| Locations | Brussels, Brussels Capital, Belgium |
| Start date | 2022-06-08 |
| NCT ID | NCT05550675 |
| Official listing | https://clinicaltrials.gov/study/NCT05550675 |